Studies how APOE isoforms affect neurons, astrocytes, and microglia and contribute to Alzheimer's disease. Combines patient-derived iPSC models, cell-type differentiation, CRISPR genome editing, next-generation sequencing, and functional neuroscience to identify cell-specific APOE4 mechanisms and therapeutic targets.